Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Gazala N. Khan"'
Autor:
Diane M. Simeone, Mark M. Zalupski, Ulysses G. Balis, Ronald Craig, John L. Blau, Gazala N. Khan, Naoko Takebe, Joel K. Greenson, Kent A. Griffith, Ethan V. Abel, Vaibhav Sahai, Edward J. Kim
Supplementary Figure 1 Legend. Median overall survival correlated with change in CA 19-9 (>50% decrease, versus {less than or equal to}50% decrease, or primary increase)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17864c07d9ce37b89b66ed47d18fc192
https://doi.org/10.1158/1078-0432.22455356
https://doi.org/10.1158/1078-0432.22455356
Autor:
Diane M. Simeone, Mark M. Zalupski, Ulysses G. Balis, Ronald Craig, John L. Blau, Gazala N. Khan, Naoko Takebe, Joel K. Greenson, Kent A. Griffith, Ethan V. Abel, Vaibhav Sahai, Edward J. Kim
Supplementary Figure 1. Median overall survival correlated with change in CA 19-9 (>50% decrease, versus {less than or equal to}50% decrease, or primary increase) compared to baseline.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c61f6e10f6eb68ead9c3b423a8b1df2
https://doi.org/10.1158/1078-0432.22455353.v1
https://doi.org/10.1158/1078-0432.22455353.v1
Autor:
Diane M. Simeone, Mark M. Zalupski, Ulysses G. Balis, Ronald Craig, John L. Blau, Gazala N. Khan, Naoko Takebe, Joel K. Greenson, Kent A. Griffith, Ethan V. Abel, Vaibhav Sahai, Edward J. Kim
Purpose: The hedgehog (HH) signaling pathway is a key regulator in tumorigenesis of pancreatic adenocarcinoma and is upregulated in pancreatic adenocarcinoma cancer stem cells (CSCs). GDC-0449 is an oral small-molecule inhibitor of the HH pathway. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e05e5a8257116fababcd5bd39db9801
https://doi.org/10.1158/1078-0432.c.6523001.v1
https://doi.org/10.1158/1078-0432.c.6523001.v1
Autor:
Diane M. Simeone, Mark M. Zalupski, Ulysses G. Balis, Ronald Craig, John L. Blau, Gazala N. Khan, Naoko Takebe, Joel K. Greenson, Kent A. Griffith, Ethan V. Abel, Vaibhav Sahai, Edward J. Kim
Supplementary Table 1. Summary of Treatment-Related Adverse Events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28abe1a90f256462e36627e451e04b81
https://doi.org/10.1158/1078-0432.22455350
https://doi.org/10.1158/1078-0432.22455350
Autor:
Mohammad Raoufi, Gazala N. Khan, David Kwon, Jia Li, Kannan Thanikachalam, Irina Dobrosotskaya, Vijay Damarla, Kenneth Winters, Ira Wollner, Trevor Seixas, Farzan Siddiqui
Publikováno v:
American journal of clinical oncology. 43(6)
Background Pancreatic ductal adenocarcinoma is a largely incurable cancer. Surgical resection remains the only potential option for cure. Even in surgically resectable patients, only about 10% to 20% are long-term survivors. Emerging data suggest a r
Autor:
Munther Ajlouni, Mira M. Shah, Gazala N. Khan, Kendyll J Gartrelle, Jadranka Dragovic, Irina Dobrosotskaya, Eric Schaff, Rupen Shah, David Kwon, Parag J. Parikh, Ibrahim Aref, Farzan Siddiqui, C. Kirsch
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e582-e583
Autor:
Mohammad Raoufi, Farzan Siddiqui, Damarla, Gazala N. Khan, Ira Wollner, David Kwon, Jia Li, D Dobrosotskaya
Publikováno v:
European Journal of Cancer. 92:S8-S9
Autor:
Gazala N. Khan, Hayan Jaratli, Joon K Lee, Farzan Siddiqui, David Kwon, Mohammad Raoufi, Irina Dobrosotskaya, Ahmed I Ghanem, Charlotte Burmeister
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 101:e4
Publikováno v:
Surgical Oncology Clinics of North America. 19:431-451
Pancreatic adenocarcinoma (PDA) is a highly lethal and aggressive malignancy with high mortality rates. It is critical to evaluate novel therapeutic strategies and targets for the treatment of this disease. In this article, the authors describe the i
Autor:
Michael A. Gorin, Gazala N. Khan, Li Wei Bao, Peiying Yang, Quintin Pan, Sofia D. Merajver, Robert A. Newman, Devin T. Rosenthal, Alison D. Pawlus, Ephraim Philip Lansky, Zhi Fen Wu
Publikováno v:
Integrative Cancer Therapies. 8:242-253
Purpose. Pomegranate fruit extracts (PFEs) possess polyphenolic and other compounds with antiproliferative, pro-apoptotic and anti-inflammatory effects in prostate, lung, and other cancers. Because nuclear transcription factor-kB (NF-kB) is known to